Phase II Study to Assess Safety, Pharmacokinetics and Efficacy of SL-1002 for Limb Spasticity
Clinical trial NCT05311215 · UNKNOWN
Trial details
- NCT number
- NCT05311215
- Sponsor
- Saol Therapeutics Inc
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-22
- Primary completion
- 2023-09-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.